Antiepileptic approved for adjunctive therapy.
D000277:Adjuvants, Pharmaceutic; D000293:Adolescent; D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009557:Nipecotic Acids / Q000627:therapeutic use*; D012640:Seizures / Q000188:drug therapy*; D000078308:Tiagabine; D014481:United States; D014486:United States Food and Drug Administration
D000277:Adjuvants, Pharmaceutic; D000927:Anticonvulsants; D009557:Nipecotic Acids; D000078308:Tiagabine